Archived Events
|
|
|
|
McCormick Place
2301 S. Lake Shore Drive
Chicago, Illinois
|
Austin Convention Center in Austin, Texas
Poster numbers: 376, 378
Author-attended session: May 20, 4:00-5:00pm
|
|
|
Orlando World Center Marriott in Orlando, Florida
|
Poster Presentation: A phase I trial of prostate-specific membrane antigen antibody-drug conjugate (PSMA ADC) in taxane-refractory prostate cancer
October 19, 2010
12:35 PM- 2:00 PM and 6:00 PM to 7:00 PM
The Westin Diplomat
Hollywood, Florida
|
Boston Convention & Exhibition Center
Poster Title: Mechanism of Action Studies of Novel Monoclonal Antibodies against Clostridium difficile Toxins
Date/Time: Monday September 13, from 11:15 am to 1:15 pm Eastern Time
|
McCormick Place
Chicago, Illinois
|
|
|
Walter E. Washington Convention Center
Washington, D.C>
|
DISCOVERY OF POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS (HCV) ENTRY WITH DISTINCT MECHANISMS OF ACTION
April 17, 2010
17:15 - 17:30
|
Loews Coronado Bay Resort
Coronado, California
|
Austin, Texas
Hilton Austin and Austin Convention Center
|
|
|
|
|
|
|
Orlando, Florida
Poster Presentation
Thursday, February 26, 2009
12:00PM - 1:15PM
Crystal Ballroom, Salon H
|
|
|
Moscone West Convention Center
San Francisco, CA
|
Walter E. Washington Convention Center
Washington, D.C.
Sunday, October 26, 2008, 11:15 a.m. – 12:15 p.m. ET
Session title: Antiretroviral Therapy: New Agents
Poster number: H-1269a
"Antiviral Activity and Tolerability of 5 mg/kg and 10 mg/kg Doses of PRO 140, a Humanized Monoclonal Antibody to CCR5"
|
44th ASCO Annual Meeting
McCormick Place
Chicago, Illinois
|
Pennsylvania Convention Center
Philadelphia, Pennsylvania
Product candidate:
Methylnaltrexone (subcutaneous)
Stage of Research:
Phase 3 abstract
Title: "Methylnaltrexone for Constipation in a Patient on Opioids with Malignant Spinal Cord Compression"
|
San Francisco, California
|
|
|
McCormick Place, Lakeside Center
Chicago, Illinois
|
Sydney Convention and Exhibition Centre
Sydney, Australia
Wednesday, July 25, 2007
4:30 p.m., Australian Eastern Standard Time
(2:30 a.m., U.S. Eastern Daylight Time)
Click here for webcast link
|
OLMA Conference Center
St. Gallen
Switzerland
Product candidate:
Methylnaltrexone (subcutaneous)
Stage of Research:
Phase 3 abstract
Title: "Methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: Results of a 3-month open-label study"
|
Crystal Gateway Marriott
Arlington, VA
Poster Session II
Tuesday, May 22, 8:00 a.m. - 7:00 p.m.
|
Washington Convention Center
Washington, DC
Methylnaltrexone Improves Opioid-Induced Constipation and
Reduces Laxative Use in Patients with Advanced Illness
Session Title: Quality of Life Research
Session Date & Time: Tuesday, May 22, 2007 from 8:00 a.m. - 5:00 p.m.
|
Sheraton Seattle Hotel and the WA State Trade and Convention Center
Seattle, WA
Thursday, May 3, 2:00 - 3:30 p.m., Poster #B36
|
Marriott Wardman Park Hotel
Washington, DC
Oral Presentation: Study 203: Phase II Intravenous MNTX POI Results
|
The Sheraton Hotel and Towers
Hong Kong, China
MNTX 301-302: Poster session #4, Fri., March 16, 1:20 - 1:30 p.m.
MNTX POI: Poster session #6, Sat., March 17, 1:20 - 1:30 p.m.
|
Orlando World Center Marriott
Orlando, FL
Session E: Sun., January 21, 7:00 - 8:00 AM
|
InterContinental Hotel
Miami, FL
Session B, Fri., December 1, 5:00 - 7:00 pm
|
Baltimore Hyatt Hotel
Baltimore, MD
Session: HIV: Advanced in Therapy, Fri., November
|
You will need Adobe® Reader® to view PDF documents.